Abstract
Background Patients with cirrhosis and hepatocellular carcinoma (HCC) require extensive and personalized care to improve outcomes. ChatGPT (Generative Pre-trained Transformer), a natural language processing model, holds potential to provide professional yet patient-friendly support.
Aim Examining the accuracy and reproducibility of ChatGPT in answering questions regarding knowledge, management, and emotional support for cirrhosis and HCC.
Method ChatGPT’s responses to 164 questions were independently graded by two transplant hepatologists and resolved by a third reviewer. The performance of ChatGPT was compared to physicians or trainees in two validated questionnaires. ChatGPT’s knowledge on cirrhosis care was tested using 26 quality measures of cirrhosis management. Finally, its emotional support capacity was tested.
Results ChatGPT regurgitated extensive knowledge of cirrhosis and HCC, but for questions with correct responses, only a small proportion was labelled as comprehensive. The performance was better in basic knowledge, lifestyle, and treatment than in the domains of diagnosis and preventive medicine. For the quality measures, the model answered 76.9% of questions correctly but failed to specify decision-making cut-offs and treatment durations. Compared to physicians/trainees, ChatGPT lacked knowledge of regional guidelines variations, such as HCC screening criteria. However, it provided practical and multifaceted advice to patients and caregivers regarding the next steps and adjusting to a new diagnosis.
Conclusion In summary, we analyzed the areas of robustness and limitations of ChatGPT’s responses on the management of cirrhosis and HCC and relevant emotional support. ChatGPT may have a role as an adjunct informational tool for patients and physicians to improve outcomes.
Conflict of Interest Disclosures None declared.
Funding/Support None
Ethics Approval Since all responses from ChatGPT were publicly available, approval from the institutional review board was not sought.
Guarantors of article:
Dr. Kuo and Spiegel
Author Contributions Concept and design: Yeo, Samaan, Spiegel, Kuo
Acquisition of data: Yeo, Samaan, Ng, Vipani
Data review: Ting, Trivedi, Kuo
Statistical analysis: Yeo
Drafting of the manuscript: Yeo, Samaan, Ng
Critical revision of the manuscript: All authors
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript or supplemental material
